Adam Levitt, MD
Vascular Surgery · Orlando, FLNPI 1881673077
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.8%), consulting fees and other — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Novapproach Spine, LLC at 29.5% of the total. Reporting peaked in 2024 at $6,658 and has fallen 74.6% since, to $1,692 in 2025.
Across 178 payments — averaging $80.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novapproach Spine, LLC$4K
- W. L. Gore & Associates, Inc.$4K
- Angiodynamics, Inc.$2K
- Boston Scientific$861
- Bard Peripheral Vascular, Inc.$747
- Silk Road Medical, Inc.$453
- plus $2K from 31 others
Across 1 payment — averaging $25,001 each. An ownership or investment interest held by the physician or an immediate family member.
- Novapproach Spine, LLC$25K
What the payments were for
- Consulting fees$4,25029%
- Travel & lodging$1,49610%
- Food & beverage$6,74847%
- Other$1,92013%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novapproach Spine, LLC | 2 | $4,250 |
| W. L. Gore & Associates, Inc. | 56 | $3,707 |
| Angiodynamics, Inc. | 3 | $1,941 |
| Boston Scientific | 15 | $861 |
| Bard Peripheral Vascular, Inc. | 15 | $747 |
| Silk Road Medical, Inc. | 7 | $453 |
| Endologix LLC | 3 | $280 |
| Cardiovascular Systems Inc. | 9 | $250 |
| Abbott | 4 | $228 |
| Philips North America LLC | 3 | $200 |
| Tactile Systems Technology Inc | 8 | $192 |
| Penumbra, Inc. | 4 | $180 |
| Smith+Nephew | 5 | $130 |
| Johnson & Johnson | 7 | $119 |
| Cvrx, Inc. | 1 | $103 |
| Medtronic(2 entities) | 3 | $102 |
| Artivion, Inc. | 2 | $75 |
| Cashflow Solutions, LLC | 4 | $69 |
| Solventum Corporation | 2 | $48 |
| Inspiremd Ltd | 3 | $41 |
| Guard Medical Inc. | 2 | $41 |
| Inari Medical, Inc. | 2 | $38 |
| Teleflex LLC | 2 | $38 |
| Organogenesis Inc. | 2 | $37 |
| Kerecis Limited | 2 | $35 |
| Baxter Healthcare | 1 | $32 |
| EKOS Corporation | 1 | $25 |
| Acera Surgical, Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $24 |
| Innovation Technologies Inc | 1 | $23 |
| Bolton Medical Inc | 1 | $23 |
| Surgenex LLC | 1 | $20 |
| Pfizer | 1 | $18 |
| Terumo Medical Corporation | 1 | $16 |
| Reflow Medical Inc | 1 | $15 |
| Sanara Medtech Inc. | 1 | $15 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OneLIF$4,250
- VenaCure 1470 Pro$1,920
- GORE TAG Thoracic Endoprosthesis$1,371
- ENROUTE Transcarotid Stent$536
- GORE TAG Thoracic Branch Endoprosthesis$387
- ENROUTE Transcarotid Neuroprotection System$328
- GORE VIABAHN VBX Balloon Expandable Endo$200
- TAG Thoracic Endoprosthesis$179
- JETi All In One Non-Sterile Kit$176
- GORE ACUSEAL Vascular Graft$165
- GORE ACUSEAL Cardiovascular Patch Vascular$163
- Fluency Endovascular Stent Graft$153
- Alto Abdominal Stent Graft System$138
- VIABAHN VBX Balloon Expandable Endoprosthesis$137
- ALTO$112
- Ovation$112
- IGT D Peripheral$107
- LIFESTREAM$105
- Barostim Neo System$103
- WATCHMAN Access System$102
How this compares
$14,414 in reported general payments places this provider in the 70th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $9,818 |
| EliquisApixaban | 14 | $7,947 |
| ClopidogrelClopidogrel Bisulfate | 138 | $1,370 |
| Cilostazol | 42 | $1,215 |
| Oxycodone Hcl | 59 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $119 | $9,81819 claims |
| PfizerEliquis | $18 | $7,94714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Orlando
- Manuel Perez IzquierdoOrlando$302K
- David VarnagyOrlando$45K
- Michael CohenOrlando$39K
- Rajendra PatelOrlando$32K
- Rachel WilsonOrlando$32K
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.